ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 102 filers reported holding ADURO BIOTECH INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,000 | -25.0% | 1,360 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | +100.0% | 1,360 | -9.3% | 0.00% | – |
| Q2 2019 | $2,000 | -66.7% | 1,500 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | +50.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2018 | $4,000 | 0.0% | 1,500 | +188.5% | 0.00% | – |
| Q3 2018 | $4,000 | -20.0% | 520 | -27.8% | 0.00% | – |
| Q2 2018 | $5,000 | -28.6% | 720 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | -96.2% | 720 | -97.1% | 0.00% | -100.0% |
| Q4 2017 | $183,000 | +1563.6% | 24,420 | +2294.1% | 0.00% | – |
| Q3 2017 | $11,000 | -8.3% | 1,020 | 0.0% | 0.00% | – |
| Q2 2017 | $12,000 | +300.0% | 1,020 | +218.8% | 0.00% | – |
| Q1 2017 | $3,000 | -57.1% | 320 | -46.7% | 0.00% | – |
| Q4 2016 | $7,000 | -74.1% | 600 | -72.7% | 0.00% | – |
| Q3 2016 | $27,000 | +8.0% | 2,200 | 0.0% | 0.00% | – |
| Q2 2016 | $25,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
| Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
| CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
| Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
| Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
| LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
| EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
| M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |